IPCA Laboratories Ltd
NSE:IPCALAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IPCA Laboratories Ltd
NSE:IPCALAB
|
IN |
|
Starbucks Corp
NASDAQ:SBUX
|
US |
|
SB Financial Group Inc
NASDAQ:SBFG
|
US |
|
Affle (India) Ltd
NSE:AFFLE
|
IN |
|
T
|
TKMS GmbH
XETRA:TKMS
|
DE |
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
|
D
|
DoorDash Inc
F:DD2
|
US |
|
S
|
Scor SE
SIX:SCR
|
FR |
|
P
|
Pylon PCL
SET:PYLON
|
TH |
|
C
|
Cascades Inc
OTC:CADNF
|
CA |
|
C
|
Credit Suisse Group AG
F:CSX
|
CH |
|
Fission Uranium Corp
TSX:FCU
|
CA |
|
Wheaton Precious Metals Corp
TSX:WPM
|
CA |
|
Mastercard Inc
NYSE:MA
|
US |
|
Subros Ltd
NSE:SUBROS
|
IN |
Wall St Price Targets
IPCALAB Price Targets Summary
IPCA Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for IPCALAB is 1 702.76 INR with a low forecast of 1 363.5 INR and a high forecast of 1 911 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IPCALAB's stock price target?
Price Target
1 702.76
INR
According to Wall Street analysts, the average 1-year price target for IPCALAB is 1 702.76 INR with a low forecast of 1 363.5 INR and a high forecast of 1 911 INR.
What is the Revenue forecast for IPCA Laboratories Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for IPCA Laboratories Ltd?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for IPCA Laboratories Ltd?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 31%.
